[Abstract] This protocol describes the application of the CRISPR-Trap from designing of the gene targeting strategy to validation of successfully edited clones that was validated on various human cell lines, among them human induced pluripotent stem cells (hiPSCs). The advantage of CRISPR-Trap over conventional approaches is the complete removal of any endogenous full-length transcript from the target gene. CRISPR-Trap is applicable for any target gene with no or little coding sequence in its first exon. Several human cell lines and different genes have so far been edited successfully with CRISPR-Trap.
. Schematic of the application of the CRISPR-Trap. The first intron of the target gene is cleaved using the CRISPR/Cas9 system and template DNA for homology-directed repair is provided.
The template DNA contains a strong 3' prime splice signal (dark green), a customizable cassette (light green) and a strong polyadenylation signal (turquoise). The customizable cassette can be utilized to either knockout (left) or replace the target gene (right). The cassette contains a selection marker that will be under the control of the endogenous promoter of the target gene upon successful editing. For gene replacements, an IRES is introduced in between the replacement gene and the selection marker. Figure adapted a. One has to be aware that the first exon of the target gene will still be expressed following the CRISPR-Trap strategy. Therefore, the ideal target gene has no or only few amino acids coded in its first exon. first exon of the target gene. Branch points are typically located < 50 nucleotides upstream of the 3' splice site, with 90% of all human branch points located 37 nucleotides upstream of the 3' splice site (Mercer et al., 2015) . However, in certain human genes, the branch point can be located further upstream. Hence, we recommend the use of a splice site predictor such as the Human Splicing Finder available at http://www.umd.be/HSF3/ to identify the ideal target region.
b. To allow direct selection for genome edited cells, the gene has to be expressed in the cells in
3. If possible, find two or more adjacent sgRNA sequences that can trigger HDR with the same donor plasmid, thereby enhancing the success rate. available as Genbank files. Furthermore, pHDR-Don example constructs for gene knockouts are provided for genes with and without coding sequence in the first exon: pHDR-Zeo-Don for genes with a non-coding first exon, pHDR-Zeo-Don_f1 for genes where the splice site after the first exon is located directly after a codon, pHDR-Zeo-Don_f2 for genes where the splice site is located after 1 extra nucleotide following the last codon, and pHDR-Zeo-Don_f3 for genes where the splice site is located after 2 extra nucleotides following the last codon. Furthermore, an example construct for gene replacement with a non-coding first exon is provided (pHDR-IRES-Puro-Don).
1. We used Zeocin and puromycin as selection markers, however, depending on the targeted cell line alternative resistance markers such as blasticidin could be beneficial.
In case that the endogenous gene contains some coding sequence in its first exon, make sure that the resistance marker/gene replacement will be spliced in-frame. 2. Use the appropriate transfection reagent for your cell line. In our hands, the most efficient transfection reagents were DogTor for HeLa cells, Mirus TransIT ® -LT1 for HT1080, and human induced pluripotent stem cells (hiPSCs) and Lipofectamine TM 3000 for SH-SY5Y neuroblastoma cells. Transfect each well with pCas9/sgRNA and pHDR-Don. Table 1 gives empirical values for successful edited cell lines in our hands (values each for the transfection of one well of a 6-well plate).
Table 1. Empirical values for amounts of transfected plasmids. Empirical values for
transfected pCas9/sgRNA and pHDR-Don plasmids in successful editings of various cell lines.
Cell line pCas9/sgRNA pHDR-Don
HeLa 2 μg 1 μg HT1080 1.5 μg 1.5 μg hiPCs 2.5 μg (+ 2.5 μg the following day) 5.5 μg (+ 5.5 μg the following day)
SH-SY5Y 1.3 μg (+ 0.8 μg the following day) 2.7 μg (+ 6.2 μg the following day)
Note: When sgRNAs for two adjacent targets were cloned, transfect 3 wells with one sgRNA and the other 3 wells with the other sgRNA. The 6-wells can also be used to vary either the total amount of transfected plasmids or the ratio between pCas9/sgRNA and pHDR-Don. A good starting point is to try molarity ratios of pCas9/sgRNA:pHDR-Don of 1:6 to 2:1. If 6-wells are not sufficient for all variation, more wells can be transfected. Since CRISPR-Trap relies on homology-directed repair, small molecules increasing the likelihood of these events such as L755507 (Yu et al., 2015; Li et al., 2017) can be added at this stage.
3. Two to four days after transfection, detach cells using the appropriate cell detachment solution and pool the cells from all wells in one 15 cm dish. Let cells attach, and then start with selection using the selection marker introduced with the cassette. Table 2 gives empirical values for successful edited cell lines in our hands. 1. Upon finishing the selection process, allow single cells to grow into colonies. It is important however to not let the colonies grow into to close proximity of one another, to ensure that each colony picked grew from one single cell. If the colonies grow to close to each other, split the cells to a new plate (use a cell strainer to ensure new colonies emerge from single cells).
Note: As rule of thumb, pick colonies consisting of at least 10 cells and 1 cm of space from the edge to the edge of the next colonies.
2. Count and note the number of colonies which are good to pick (i.e., consisting of at least 10 cells and 1 cm of space from the edge to the edge of the next colonies). Use a pen to mark all colonies which are good to pick by circling them on the underside of the 15 cm plate (see Figure   3 ).
Note: If two colonies are too close to each other, forego to pick them to avoid picking of mixed colonies.
3. Apply vacuum grease on a fresh sterile dish and use a sterile cell scraper to generate a grease film of approximately 5 mm thickness ( Figures 3A and 3B ). 10. Let the colonies grow over the next couple of days in the 24-well plate and transfer the cells into a well of a 6-well plate as soon as they reach confluence.
Note: It is also possible to harvest clones directly from 24-wells following the same protocol from Procedure D.
D. Validation of successful edited clones 1. As soon as the clones reach confluence on the 6-well plates (or 24-well plates), detach the cells and split them into two parts. Freeze half the cells to continue with in case of a successful genome editing, while extracting the DNA and RNA from the other half to assess the genotype.
Hereto we re-suspend the cells in TRIZOL to isolate gDNA as well as RNA.
Note: A DNA extraction kit can be used as an alternative to the extraction using TRIZOL. The advantage of the TRIZOL extraction, however, is the possibility to simultaneously extract RNA.
Using RT-qPCR allows for a quick check if any RNA from the target gene downstream from the introduced gene trap is expressed. Low traces of such RNA can indicate a mixed population of cells (picked clone originates not from a single cell).
Furthermore, samples in TRIZOL can be stored for long-term at -20 °C allowing batch analysis of a high number of clones simultaneously.
